Stocktoria
TREACE MEDICAL CONCEPTS, INC. TMCI
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-04-23
TREACE MEDICAL CONCEPTS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 79.8% | 80.4% | 81.2% | 82.0% | 82.1% |
| Operating margin | -25.5% | -26.6% | -27.5% | -24.6% | -17.5% |
| Net margin | -27.7% | -26.6% | -26.5% | -30.2% | -21.8% |
| FCF margin | -13.9% | -23.3% | -24.6% | -32.1% | -21.1% |
| Return on assets | -31.0% | -25.7% | -19.7% | -26.9% | -14.6% |
| Return on equity | -67.6% | -49.4% | -35.9% | -70.7% | -22.1% |
| Debt / equity | 0.64× | 0.47× | 0.38× | 0.87× | 0.32× |
| Current ratio | 4.31 | 4.62 | 4.40 | 4.41 | 7.58 |
| Revenue growth | 1.6% | 11.9% | 31.9% | 50.2% | 64.6% |
Source: SEC EDGAR filings · CIK 0001630627 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.